Article List

WPRIM Management System> DCMS> Journal of the Korean Gastric Cancer Association> 2005> 5

Volume: 5

1. Correlation between Infiltrations of Tumor-associated Macrophages, Mast Cells, and Dendritic Cells with Clinicopathologic Factors in Advanced Gastric Cancer.	Page:206—212
2. Expression Pattern of KLF4 in Korean Gastric Cancers.	Page:200—205
3. Suppression of Helicobacter pylori-induced Angiogenesis by a Gastric Proton Pump Inhibitor.	Page:191—199
4. The Accuracy of Imprint Cytology in the Intraoperative Diagnosis of Lymph Node Metastasis in Gastric Cancer Surgery.	Page:186—190
5. Expression of MAGE in Gastric Cancer Tissues.	Page:180—185
6. Can 3-year Disease-free Survival be Substituted for 5-year Overall Survival in Curatively Resected Gastric Cancer?.	Page:174—179
7. Clinicopathologic Evaluation of Gastric Polyps Remainding in the Stomach after a Gastrectomy.	Page:169—173
8. Comparison of Nodal Staging, of UICC TNM and Japanese Classification, and Prognostic Nodal Grouping of UICC N3M0 in Advanced Gastric Cancer.	Page:163—168
9. Clinical Correlation between the Serum Pepsinogen I/II Ratio and Gastric Cancer.	Page:158—162
10. Assessment of Nutrition Status and Quality of Life after Curative Resection in Patients with Upper Gastric Cancer: Comparison of Total Gastrectomy and Proximal Gastrectomy.	Page:152—157
11. Preoperative and Postoperative Anemia in Patients with Gastric Cancer.	Page:146—151
12. Preoperative Chemotherapy in Gastric Cancer.	Page:139—145
13. Clinicopathological Characteristics of Superficially Spreading Early Gastric Cancer.	Page:288—294
14. Impact of Adjuvant Chemoradiation Therapy on the Postoperative 5-year Survival Rates for Stage-II Gastric Cancer.	Page:281—287
15. Cyclin G2 Expression in Gastric-cancer Tissues.	Page:273—280
16. Clinicopathological Characteristics of Superficially Spreading Early Gastric Cancer.	Page:288—294
17. Clinicopathologic Risk Factors of Hepatic Recurrence after Curative Resection for Gastric Cancer.	Page:266—272
18. Impact of Adjuvant Chemoradiation Therapy on the Postoperative 5-year Survival Rates for Stage-II Gastric Cancer.	Page:281—287
19. Cyclin G2 Expression in Gastric-cancer Tissues.	Page:273—280
20. Clinicopathologic Risk Factors of Hepatic Recurrence after Curative Resection for Gastric Cancer.	Page:266—272
21. Clinicopathologic Characteristics of and Surgical Strategy for Patients with Submucosal Gastric Carcinomas.	Page:89—94
22. Clinicopathologic Characteristics of and Surgical Strategy for Patients with Submucosal Gastric Carcinomas.	Page:89—94
23. Quality Assurance of Gastric Cancer Surgery.	Page:79—88
24. Quality Assurance of Gastric Cancer Surgery.	Page:79—88
25. Hepatoid Adenocarcinoma of the Stomach with Liver Metastasis.	Page:127—132
26. Role of Endoscopic Ultrasonography in the Diagnosis of Gastrointestinal Stromal Tumors in the Stomach.	Page:120—126
27. The Significance of Lymphatic, Venous, and Neural Invasion as Prognostic Factors in Patients with Gastric Cancer.	Page:113—119
28. The Distribution Pattern of Lymphocyte Subsets according to the Level of Serum Albumin in Preoperative Patients with Gastric Cancer.	Page:106—112
29. Hepatoid Adenocarcinoma of the Stomach with Liver Metastasis.	Page:127—132
30. Clinical Significance of Subdividing Gastric Cancer according to the Degree of Invasion of the Muscularis Propria.	Page:101—105
31. Role of Endoscopic Ultrasonography in the Diagnosis of Gastrointestinal Stromal Tumors in the Stomach.	Page:120—126
32. Critical Pathway for Operable Gastric Cancer.	Page:95—100
33. The Significance of Lymphatic, Venous, and Neural Invasion as Prognostic Factors in Patients with Gastric Cancer.	Page:113—119
34. The Distribution Pattern of Lymphocyte Subsets according to the Level of Serum Albumin in Preoperative Patients with Gastric Cancer.	Page:106—112
35. Clinical Significance of Subdividing Gastric Cancer according to the Degree of Invasion of the Muscularis Propria.	Page:101—105
36. Critical Pathway for Operable Gastric Cancer.	Page:95—100
37. Curative Resection of Inoperable, Locally Advanced Gastric Cancer after Neoadjuvant Chemotherapy with Taxotere and Cisplatin.	Page:57—64
38. A Case of Locally Recurrent Gastric Cancer at Kim's Tie Site of the Jejunum after a Total Gastrectomy.	Page:52—56
39. A Case of Eosinophilic Gastritis Mimicking Borrmann Type-4 Advanced Gastric Cancer.	Page:47—51
40. Gastrointestinal Stromal Tumor (GIST) of the Stomach: Clinicopathologic Analysis and Outcome.	Page:40—46
41. Expression Pattern of KLF6 in Korean Gastric Cancers.	Page:34—39
42. Prognostic Values of Preoperative Hematologic Parameters in Gastric Cancer.	Page:29—33
43. Bone Metastasis after a Curative Resection for Gastric Cancer.	Page:23—28
44. The Early Experience with a Totally Laparoscopic Distal Gastrectomy.	Page:16—22
45. Methylenetetrahydrofolate Reductase C677T Polymorphism in Gastric Cancer.	Page:10—15
46. Transhiatal Esophagectomy in Cardia and Esophageal Cancer.	Page:1—9
47. Mutation of the Chk1 Gene in Gastric Cancers with Microsatellite Instability.	Page:260—265
48. Clinical Experience of Small-cell Carcinomas of the Stomach.	Page:252—259
49. Benign Stricture of Esophagojejunostomy after Radical Total Gastrectomy.	Page:246—251
50. Clinical Significance of the Ghrelin Concentrations in Plasma and Tumor Tissue from Patients with Gastric Cancer.	Page:238—245
51. Methylation of P16 and hMLH1 in Gastric Carcinoma.	Page:228—237
52. Positive Rate of Tumor Marker according to Sites of Recurrence in Gastric Cancer.	Page:222—227
53. Operative Treatment of Patients Over 75 Years Old with Gastric Cancer.	Page:217—221